Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04514497
Title Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)

lung small cell carcinoma

neuroendocrine carcinoma

pancreatic adenocarcinoma

Advanced Solid Tumor


BAY1895344 + Irinotecan

BAY1895344 + Topotecan

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.